Abstract
Previous studies on the natural product chlorofusin have shown that the full peptide and azaphilone structure are required for inhibition of the interaction between MDM2 and p53. In the current work, we utilized the cyclic peptide as a template and introduced an azidonorvaline amino acid in place of the ornithine/azaphilone of the natural product and carried out click chemistry with the resulting peptide. From this small library the first ever non-azaphilone containing chlorofusin analogue with MDM2/p53 activity was identified. Further studies then suggested that the simple structure of the Fmoc-norvaline amino acid that had undergone a click reaction was also able to inhibit MDM2/p53 interaction. This is an example where studies of a natural product have led to the serendipitous identification of a new small molecule inhibitor of a protein-protein interaction.
Original language | English |
---|---|
Pages (from-to) | 4878-4880 |
Number of pages | 3 |
Journal | Bioorganic & Medicinal Chemistry Letters |
Volume | 25 |
Issue number | 21 |
Early online date | 14 Jun 2015 |
DOIs | |
Publication status | Published - 1 Nov 2015 |
Keywords
- MDM2
- Natural product
- Protein-Protein Interactions
- P53
- Chlorofusin
Profiles
-
Maria O'Connell
- Faculty of Science - Associate Dean for Research
- School of Chemistry, Pharmacy and Pharmacology - Professor of Cell Biology
- Molecular and Tissue Pharmacology - Group Lead
- HealthUEA - Steering Committee Member
Person: Research Group Member, Academic, Teaching & Research
-
Mark Searcey
- School of Chemistry, Pharmacy and Pharmacology - Professor
Person: Research Centre Member, Academic, Teaching & Research